期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
利用TCGA数据集分析SLC16A3和SLC27A3在肺腺癌中的表达及临床意义
1
作者 庄彬彬 曹鹏驹 陈少婷 《中文科技期刊数据库(文摘版)医药卫生》 2024年第11期0042-0050,共9页
探究SLC16A3和SLC27A3在肺腺癌及其癌旁组织中的表达及临床意义。方法 从癌症基因组图谱(TCGA)数据库下载517例肺腺癌组织(肿瘤组)与59例癌旁组织(癌旁对照组)RNAseq 数据及对应的肺腺癌患者临床数据,对数据中SLC16A3和SLC27A3基因表达... 探究SLC16A3和SLC27A3在肺腺癌及其癌旁组织中的表达及临床意义。方法 从癌症基因组图谱(TCGA)数据库下载517例肺腺癌组织(肿瘤组)与59例癌旁组织(癌旁对照组)RNAseq 数据及对应的肺腺癌患者临床数据,对数据中SLC16A3和SLC27A3基因表达进行分析处理。比较其表达与肺腺癌临床病理特征的相关性及对预后的影响。采用生存分析及ROC评估SLC16A3和SLC27A3的临床预后及诊断价值。结果 在肺腺癌中SLC16A3(P = 0.0147)和SLC27A3(P < 0.0001)启动子甲基化水平上调。SLC16A3的mRNA及蛋白水平升高(P < 0.0001),而SLC27A3则下调(P < 0.0001);SLC16A3与患者T分期、N分期、TNM分期相关。SLC27A3与TNM分期相关。SLC16A3表达水平越高预示患者总体生存期(overall survival, OS)越差,而对无复发生存期(recurrence-free survival, RFS)无显著影响;SLC27A3低表达预示患者OS时间更短,而对RFS无显著影响。结论 SLC16A3高表达可做为独立预后危险因素,面SLC27A3高表达为保护因素。SLC16A3和 SLC27A3具有成为肺腺癌诊断及预测预后标志物的潜能。 展开更多
关键词 肺腺癌 slc16a3 SLC27A3 生存分析 诊断效能
下载PDF
Exosomes originating from neural stem cells undergoing necroptosis participate in cellular communication by inducing TSC2 upregulation of recipient cells following spinal cord injury
2
作者 Shiming Li Jianfeng Li +5 位作者 Guoliang Chen Tao Lin Penghui Zhang Kuileung Tong Ningning Chen Shaoyu Liu 《Neural Regeneration Research》 SCIE CAS 2025年第11期3273-3286,共14页
We previously demonstrated that inhibiting neural stem cells necroptosis enhances functional recovery after spinal cord injury.While exosomes are recognized as playing a pivotal role in neural stem cells exocrine func... We previously demonstrated that inhibiting neural stem cells necroptosis enhances functional recovery after spinal cord injury.While exosomes are recognized as playing a pivotal role in neural stem cells exocrine function,their precise function in spinal cord injury remains unclear.To investigate the role of exosomes generated following neural stem cells necroptosis after spinal cord injury,we conducted singlecell RNA sequencing and validated that neural stem cells originate from ependymal cells and undergo necroptosis in response to spinal cord injury.Subsequently,we established an in vitro necroptosis model using neural stem cells isolated from embryonic mice aged 16-17 days and extracted exosomes.The results showed that necroptosis did not significantly impact the fundamental characteristics or number of exosomes.Transcriptome sequencing of exosomes in necroptosis group identified 108 differentially expressed messenger RNAs,104 long non-coding RNAs,720 circular RNAs,and 14 microRNAs compared with the control group.Construction of a competing endogenous RNA network identified the following hub genes:tuberous sclerosis 2(Tsc2),solute carrier family 16 member 3(Slc16a3),and forkhead box protein P1(Foxp1).Notably,a significant elevation in TSC2 expression was observed in spinal cord tissues following spinal cord injury.TSC2-positive cells were localized around SRY-box transcription factor 2-positive cells within the injury zone.Furthermore,in vitro analysis revealed increased TSC2 expression in exosomal receptor cells compared with other cells.Further assessment of cellular communication following spinal cord injury showed that Tsc2 was involved in ependymal cellular communication at 1 and 3 days post-injury through the epidermal growth factor and midkine signaling pathways.In addition,Slc16a3 participated in cellular communication in ependymal cells at 7 days post-injury via the vascular endothelial growth factor and macrophage migration inhibitory factor signaling pathways.Collectively,these findings confirm that exosomes derived from neural stem cells undergoing necroptosis play an important role in cellular communication after spinal cord injury and induce TSC2 upregulation in recipient cells. 展开更多
关键词 cellular communication competing endogenous RNA EXOSOMES Foxp1 NECROPTOSIS neural stem cells slc16a3 spinal cord injury transcriptome sequencing Tsc2
下载PDF
Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma
3
作者 Ting Zhu Xiaoqin Ge +4 位作者 Shengping Gong Shenchao Guo Qingsong Tao Jianxin Guo Ruishuang Ma 《Cancer Innovation》 2022年第3期229-239,共11页
Background:Hypoxic microenvironment is immunosuppressive and protu-morigenic,and elevated lactate is an intermediary in the modulation of immune responses.However,as critical lactate transporters,the role of SLC16A1 a... Background:Hypoxic microenvironment is immunosuppressive and protu-morigenic,and elevated lactate is an intermediary in the modulation of immune responses.However,as critical lactate transporters,the role of SLC16A1 and SLC16A3 in immune infiltration and evasion of glioma is not fully elucidated.Methods:Gene expression in low‐and high‐grade glioma(LGG and GBM)was evaluated with TCGA database.The TISIDB,TIMER and CIBERSORT databases were utilized for the analysis of the correlation between SLC16A1 or SLC16A3 and immunocyte infiltration as well as immune checkpoints.Results:Compared with normal tissues,a significant increase of both SLC16A1 and SLC16A3 was found in LGG and GBM,and closely related to the poor prognosis only in LGG.Cancer SEA indicated that SLC16A1 was involved in hypoxia while SLC16A3 contributed to metastasis and inflamma-tion in glioma.The SLC16A3 expression was significantly correlated with neutrophil activation by GO analysis.TISCH showed the distribution of SLC16A1 on glioma cells and SLC16A3 on immune cells,which was correlated to tumor‐associated macrophages and neutrophils that are immunosuppressive.SLC16A1 and SLC16A3 were identified to tightly interacted with diverse immune checkpoints(especially PD1,PD‐L1,PD‐L2,Tim‐3)and immunosuppressive factors(TGF‐βand IL‐10)in glioma.Furthermore,SLC16A3 had a positive correlation to activation markers of tumor‐associated neutrophils and chemokines such as CCL2,CCL22,CXCR2,CXCR4 in LGG and CCL7,CCL20 CXCL8 in GBM,which could enhance infiltration of immunosuppressive cells to the tumor microenvironment.Conclusion:In general,our results suggest that SLC16A1 and SLC16A3 act as a bridge between tumor metabolism and immunity by promoting immuno-suppressive cell infiltration,which contributes to immune evasion and a worse prognosis in glioma.Targeting SLC16A1 and SLC16A3 may provide novel therapeutic strategy for immunotherapy in glioma. 展开更多
关键词 GLIOMA SLC16A1(MCT1) slc16a3(MCT4) immune checkpoints immune evasion
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部